Korro Bio was founded to turn extraordinary scientific insights into life-altering new treatments for patients. We harness the body’s natural RNA editing machinery to make precise, single-base RNA edits to modulate protein function, addressing the medical needs of patients. Our mission is to rewrite the future for patients living with debilitating disease by repairing the underlying genetic cause.
Location: United States, Massachusetts, Cambridge
Member count: 51-200
Total raised: $207.5M
Founded date: 2018
Investors 3
| Date | Name | Website |
| 29.12.2021 | New Enterp... | nea.com |
| - | Atlas Vent... | atlasventu... |
| - | MP Healthc... | mp-healthc... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 05.01.2022 | Series B | $116M | - | mp-healthc... |
| 10.09.2020 | Series A | $91.5M | - | citybizlis... |
Mentions in press and media 14
| Date | Title | Description | Source |
| 06.01.2022 | Early stage startups doubled their funding in 2021 | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 06.01.2022 | Early stage startups doubled their funding in 2021 | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 06.01.2022 | Korro Bio secures $116M Series B | Korro Bio has raised $116 million in a round led by Eventide Asset Management. Based in the Boston a... | pitchbook.... |
| 05.01.2022 | Korro Bio Closes $116M Series B Financing | Korro Bio, Inc., a Cambridge, Mass.-based RNA editing company focused on the discovery and developme... | finsmes.co... |
| 05.01.2022 | Korro Bio Completes $116M Series B Financing to Expand the F... | - | mp-healthc... |
| 05.01.2022 | Korro Bio Completes $116M Series B | CAMBRIDGE, MA, Korro Bio, an RNA editing company, announced the completion of a $116M Series B fin... | vcnewsdail... |
| 14.09.2020 | RNA Therapeutics Company Korro Bio Raises $91.5 Million | RNA therapeutics company Korro Bio announced recently that it has raised $91.5 million in a Series A... | pulse2.com... |
| 14.09.2020 | China’s Wu Capital leads $91.5m Series A round in genetic fi... | Premium Cambridge-based biotech startup Korro Bio has raised $91.5 million in a Series A funding ro... | dealstreet... |
| 10.09.2020 | Korro Bio Closes $91.5 Million Series A Financing | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Korro Bio, Inc. today announced a $91.5 million Series A financin... | citybizlis... |
| 10.09.2020 | Korro Bio hits the high notes with $91.5M series A to run it... | Korro Bio has got off a meaty series A funding round, nabbing $91.5 million to run its platform of s... | fiercebiot... |
Show more